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Abstract. Mammographic features such as small vague densities, indefinable microct 
subtle architectural distortions, alone or in combination, are non-specific appearances ior breast 
cancer. These features sometimes precede malignancy and a decisive strategy on how to deal with 
non-specific minimal signs in a breast cancer screening programme is 
studying the prevalence of these signs in a Dutch Breast Cancer Screening Centre and estimating 
the risk  of participants with these signs acquiring breast cancer within 2 years, we have 
such a strategy. Non-specific minimal signs were seen on the mammograms of 53 of 500 (10.6%) 
participants, aged 50-70 years, in this programme. After retrospective analysis of the mammograms 
of 254 patients with screen-detected or interval carcinoma, non-specific minimal signs were detected 
in 77 cases. Combining the incidence of breast cancer with the difference between the expected 
num ber of non-specific minimal signs in the screening programme and its actual occurrence in 
previous mammograms of patients with breast cancer, the risk of cancer in women with these 
signs, additional to that of screened women in general (additional risk), is calculated as being 
0.5%. Invasive breast cancer in women with previously detected non-specific minimal signs dem on­
strated a favourable stage at diagnosis (axillary metastasis in 23% vs 37% in cancers without these 
previous signs, ¿><0.05). O ur strategy for follow-up in case of non-specific minimal signs remains 
unchanged because of the low additional risk and favourable staging, and is restricted to an 
invitation for the next screening round in 2 years time.
Introduction
The value of mammography in decreasing 
breast cancer mortality has been proven [1-3]. 
Interpretation of screening mammograms can 
sometimes be difficult. In some cases non-specific 
minimal signs such as small vague densities, a few 
clustered indefinable microcalcifications, subtle 
architectural distortions or combinations of these 
findings can  be confusing, even for experienced 
screening radiologists. These signs are not specific 
for either malignant or benign lesions and often 
remain unchanged or disappear with time. As these 
signs sometimes precede malignancy, as well as 
representing benign lesions, it is difficult to decide 
how to m anage a case with a non-specific mini­
mal sign.
These signs are sometimes only detected during 
follow-up o r  review of a case. The study of these
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signs on screening mammography is c 
be important [4] and may help to i
t o
sensitivity for malignancy. At present the preva­
lence and ance of these in breast
cancer screening are not known.
In the first part of this study, the prevalence of
non-specific minimal signs was assessed in screened
women aged 50-70 years. In the second part, the
risk of breast cancer developing within 2 years was
retrospectively estimated in participants showing
these signs on a previous screening mammogram.
Based on these results, we evaluated the current
method of managing non-specific minimal signs in
mammographic screening and defined our future 
strategy.
Materials and methods
In most districts in The Netherlands, women of 
50-70 years of age are invited biennially for mam­
mographic screening in mobile units. Medio-lateral 
oblique and cranio-caudal views are obtained in 
the first screening round. Only oblique m am m o­
grams are performed at subsequent screening visits 
unless there is a change when compared with
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one or more screening
or Nijmegen, were Carcinomas were
detected in a subsequent screening round (screen- 
detected carcinomas) in 165 patients, and the diag­
nosis was made in the period between two consecu­
tive screening rounds {interval carcinoma) in 
cases. T um our size, histological type and the pres­
ence of axillary metastatic lymph nodes for cancers
without non-specific minimal signs, asw i a
retros
■ior to the one at which the diagnosis
In the first part of the study minimal signs were
m am m ogram s of 53 of 
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or two non-s
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tities (Figure 1);
( 15.1%) asymmetrical glandular tissue; four (7.
and three (5.
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Figure 1. (a) Oblique and (b) cranio-caudal mammograms with a vague density, (c) Oblique and (d) cranio-caudal 
mammograms of the same breast 2 years later with suspicious density, histologically proven invasive carcinoma.
Table 1. Characteristics of 254 breast cancers
Classification of previous mammogram
Total ( %) Screening 
error or 
technically 
imperfect
film (%)
Non-specific 
sign present 
(%)
Non-specific
sign
absent (%)
Interval 
cancer 
occult at 
diagnosis 
(%)
Number:
Interval cancer 
Screen-detected cancer
89 (100%) 
165 (100%)
7 (8%) 
23 (14%)
24 (27 %) 
53 (32%)
49 (55%) 
89 (54%)
9 (10%)
Histological type: 
Ductal in situ 
Ductal invasive 
Lobular invasive 
Other 
Unknown
25 (100%) 
188 (100%) 
21 (100%) 
15 (100%) 
5 (100%)
25 (13%) 
3 (14%) 
2 (13%)
11 (44%) 
54 (29%) 
4(19%) 
8 (53%)
14 (56%) 
107 (57%) 
12 (57%) 
5 (33%)
2 ( 1 %) 
2(10%)
5 (100%)
Tumour diameter at histology: 
<10 mm 
10-20 mm 
>20 mm 
Unknown
68 (100%) 
118 (100%) 
63 (100%) 
5 (100%)
5 (7%)
8 (7%) 
17 (27%)
25 (37%) 
40 (34%) 
12 (19%)
38 (56%) 
68 (58%) 
32 (51%)
2 (2%)
2 (2%)
5 (100%)
Total number 254(100%) 30(12%) 77 (30%) 138 (54%) 9 (4%)
of the 255 cancers would have previously demon­
strated such a sign. About 10000 out of 100000 
screened women will therefore show these signs, of
which 90 would be expected to be diagnosed as 
having cancer within 2 years. This represents a 
0.90% chance of developing breast cancer within
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Table 4. Presence of axillary métastasés in mammographically detected tumours with and without non-specific minimal 
signs on the correctly-judged previous mammogram
10-20 mm 
> 20 mm
Total number
Tumours without previous 
non-specific minimal signs
Screen-detected Interval
Axillary métastasés absent 
Axillary métastasés present
Tumour diameter 
< 10 mm
59 (66%) 
30 (34%)
22 (25%) 
47 (53%) 
2 0  (2 2 % )
89 (100%)
28 (57%) 
21 (43%)
16 (33%) 
21 (43%) 
12 (24%)
49 ( 100 % )
Tumours with previous non-specific 
specific minimal signs
Screen-detected Interval
45 (85%) 
8 (15%)
14 (58%) 
10 (42%)
18 ( 34 % ) 
24 (45%) 
1 1 ( 2 1  %  )
5 3  ( 1 0 0  %  )
7 (29%) 
16 (67%)
1 (4%)
24 (100%)
that false negatives are not acceptable and that all 
non-specific minimal signs need immediate further 
diagnostic assesment; such as ultrasound, MRI or 
needle core biopsy [9, 10]. Sickles [11] found that 
only 0.5% of 3184 biopsies taken from non- 
palpable mammographically detected but probably 
benign lesions turned out to be malignant. The 
tumour size and actual tumour stage at the 
moment of detection are also relevant when decid­
ing how to deal with these signs. In our study, 
there was no difference in size and favorable staging 
for tumours with, previous non-specific minimal 
signs. Immediate diagnostic assessment of all these 
signs in a screening programme would lead to a 
large number of false positives and result in 
unnecessary emotional distress and physical dis­
comfort in a large number of women. Diagnostic 
evaluation of all these signs would increase our 
recall rate about eightfold, from 1.3% after the 
first screening round and 0.65% after following 
rounds [5 ] to about 10% overall. According to a 
nationally agreed consensus the positive predictive 
value of the screening programme should be, for 
cost-effective reasons, over 30% in the first round 
and over 50% during following rounds [12].
Follow-up of women with non-specific mini­
mal signs in our district is therefore restricted to 
an invitation for the next screening-round. 
Considering the relatively low additional risk of 
0.5% for participants in the screening with non­
specific minimal signs of developing breast cancer 
and the favourable stage of disease in these breast 
cancers, regular follow-up in the next screening 
round seems to be a reasonable option.
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